HER2+ mBC: Emerging Agents in the Third-Line and Higher Setting
Debu Tripathy, MD, discusses novel therapies being developed for later-line treatment of HER2+ mBC.
Source: onclive.com
Stay updated with breaking news from Tulip Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Debu Tripathy, MD, discusses novel therapies being developed for later-line treatment of HER2+ mBC.